SINOVAC BIOTECH LTD
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-198.8M | $40.7M | $-13.5M | $14.5M | $8.12B | $110.4M | $44.9M | $21.8M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $97.4M | $110.2M | $157.4M | $152.7M | $85.1M | $3.7M | $4.6M | $4.9M |
| Amortization | $1.3M | $1.1M | $998.0K | $445.0K | $183.0K | $106.0K | $0 | $0 |
| Stock-Based Compensation | — | $0 | $0 | $0 | $7.7M | $10.2M | $3.0M | $4.3M |
| Net Cash from Operating Activities | $-512.2M | $-56.9M | $138.6M | $-798.1M | $15.32B | $479.3M | $39.1M | $7.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $48.9M | $96.0M | $156.2M | $313.9M | $594.2M | $127.5M | $10.6M | $5.6M |
| Business Acquisitions | $14.1M | $100.2M | $0 | $0 | $0 | — | — | — |
| Net Cash from Investing Activities | $4.39B | $456.4M | $-2.70B | $-6.09B | $-2.98B | $-204.8M | $-42.5M | $-25.3M |
| Financing Activities | ||||||||
| Dividends Paid | $3.53B | $947.0M | $328.1M | $247.4M | $1.88B | $0 | $0 | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-3.43B | $-824.0M | $-88.6M | $-299.5M | $-1.91B | $592.6M | $1.7M | $64.2M |
| Net Change in Cash | $554.2M | $-526.9M | $-2.76B | $-7.73B | $10.57B | $894.3M | $-2.3M | $42.2M |
| Free Cash Flow | $-561.1M | $-152.9M | $-17.5M | $-1.11B | $14.73B | $351.8M | $28.4M | $2.3M |